Skip to content

A study to observe the effects of a treatment option for acne scars

The efficacy and safety of MNRF with PRP or MNRF alone in the treatment of facial acne scars in patients at a tertiary care teaching hospital- a prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067801
Enrollment
27
Registered
2024-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L705- Acne excoriee Health Condition 2: L700- Acne vulgaris Health Condition 3: L709- Acne, unspecified Health Condition 4: L909- Atrophic disorder of skin, unspecified Health Condition 5: L708- Other acne Health Condition 6: L908- Other atrophic disorders of skin Health Condition 7: L905- Scar conditions and fibrosis of skin

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Silpa Rajesh Raj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with acne scarring aged 18 years or above are included.

Exclusion criteria

Exclusion criteria: Those with known photosensitivity, pregnancy, lactation, keloidal tendency, use of oral retinoids in last 6 months, infections like herpes labialis and history of pacemaker implantation are excluded.

Design outcomes

Primary

MeasureTime frame
To assess the improvement of facial acne scars qualitatively, quantitatively and subjectively in terms of percentages. To monitor the various side effects that can occur during the procedure.Timepoint: Monthly for 4 months

Secondary

MeasureTime frame
To monitor the various side effects that can occur during the procedure.Timepoint: Monthly for 4 months

Countries

India

Contacts

Public ContactDr Sathish Pai B

Kasturba Medical College Manipal

drsbpai@yahoo.co.in9900405072

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026